Prognostic significance of hepatocyte growth factor activator inhibitor type 1 (HAI-1) immunoreactivity in pancreatic ductal adenocarcinoma

Table 1 Association between clinicopathological parameters and diffuse HAI-1 immunoreactivity

Parameters	Cases	HAI-1 diffuse^a	p value^b
Gender
Female	33	17	0.280
Male	34	22
Age
≥ 70	35	27	0.001
< 70	32	12
T factor
T1 + T2	11	7	0.690
T3 + T4	56	32
Lymph node metastasis
+	44	26	0.840
−	23	13
Tumor grade
Well/moderate	51	30	0.856
Poor	16	9
Adjuvant therapy
(+)	45	27	0.671
(−)	22	12

ISSN: 1756-0500